openPR Logo
Press release

Warm Autoimmune hemolytic anemia (WAIHA) Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | Rigel Pharma, Incyte Crp., Sanofi, Johnson & Johnson, Janssen R&D

01-14-2025 02:48 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Warm Autoimmune hemolytic anemia (WAIHA) Market Poised

The Key Warm Autoimmune hemolytic anemia Companies in the market include - Zenas BioPharma, Novartis, MorphoSys, Alpine Immune Sciences, Rigel Pharma, Incyte Corp, Sanofi, Johnson & Johnson, Janssen Research & Development, Annexon, Inc., Apellis Pharma, Rigel Pharmaceuticals, Hutchison Medipharma Limited, and others.
DelveInsight's "Warm Autoimmune hemolytic anemia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Warm Autoimmune hemolytic anemia, historical and forecasted epidemiology as well as the Warm Autoimmune hemolytic anemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

To Know in detail about the Warm Autoimmune hemolytic anemia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Warm Autoimmune hemolytic anemia Market Forecast [https://www.delveinsight.com/sample-request/warm-autoimmune-hemolytic-anemia-waiha-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Some of the key facts of the Warm Autoimmune hemolytic anemia Market Report:

*
The Warm Autoimmune hemolytic anemia market size was valued approximately USD 300 Million in the year 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)

*
In February 2024, Novartis declared its intention to initiate a voluntary public takeover bid to acquire MorphoSys through an agreement.

*
The total market size for wAIHA in the US was estimated at approximately USD 200 million in 2023, with expectations for growth during the forecast period (2024-2034).

*
In 2023, Germany held the largest market share for wAIHA in the EU4 and the UK, with a market size of USD 20 million, and this is projected to grow during the forecast period (2024-2034).

*
By 2034, Nipocalimab (M281) is expected to generate the highest revenue among emerging therapies for wAIHA in Japan.

*
In 2023, the US had the highest number of prevalent cases of autoimmune hemolytic anemia among the 7MM, with approximately 57,000 cases. This figure is expected to rise throughout the forecast period.

*
In 2023, females represented a significant portion of gender-specific prevalent cases of wAIHA, accounting for up to 60% of cases. These cases are projected to rise by 2034 in the US.

*
In 2023, Germany reported the highest number of prevalent cases of wAIHA among the EU4 and the UK, while Spain had the lowest.

*
Estimates indicate that in Japan, the highest prevalence of wAIHA was observed in the greater than or equal to 65 age group, making up over 64% of total cases in 2023.

*
Key Warm Autoimmune hemolytic anemia Companies: Zenas BioPharma, Novartis, MorphoSys, Alpine Immune Sciences, Rigel Pharma, Incyte Corp, Sanofi, Johnson & Johnson, Janssen Research & Development, Annexon, Inc., Apellis Pharma, Rigel Pharmaceuticals, Hutchison Medipharma Limited, and others

*
Key Warm Autoimmune hemolytic anemia Therapies: Obexelimab (ZB012), Ianalumab, Povetacicept, Fostamatinib, Parsaclisib, Rilzabrutinib, Nipocalimab, M281, ANX005, APL-2, Fostamatinib disodium, HMPL-523(300mg PO QD), and others

*
The Warm Autoimmune hemolytic anemia epidemiology based on gender analyzed that in case of Warm Autoimmune hemolytic anemia, gender ratio revealed preponderance of the female gender over the male counterpart

*
The Warm Autoimmune hemolytic anemia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Warm Autoimmune hemolytic anemia pipeline products will significantly revolutionize the Warm Autoimmune hemolytic anemia market dynamics.

Warm Autoimmune hemolytic anemia Overview

Warm Autoimmune Hemolytic Anemia (WAIHA) is a condition where the immune system mistakenly attacks and destroys its own red blood cells at normal body temperatures. This leads to anemia, a shortage of red blood cells, causing symptoms like fatigue, pale skin, jaundice, and an increased heart rate. The exact cause of WAIHA is often unknown but can be linked to other conditions, such as autoimmune disorders, infections, or certain medications. Treatment typically involves managing the underlying cause, medications to suppress the immune system, and in some cases, blood transfusions.

Get a Free sample for the Warm Autoimmune hemolytic anemia Market Report:

https://www.delveinsight.com/report-store/warm-autoimmune-hemolytic-anemia-waiha-market [https://www.delveinsight.com/report-store/warm-autoimmune-hemolytic-anemia-waiha-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Warm Autoimmune hemolytic anemia Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Warm Autoimmune hemolytic anemia Epidemiology Segmentation:

The Warm Autoimmune hemolytic anemia market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:

*
Total Prevalence of Warm Autoimmune hemolytic anemia

*
Prevalent Cases of Warm Autoimmune hemolytic anemia by severity

*
Gender-specific Prevalence of Warm Autoimmune hemolytic anemia

*
Diagnosed Cases of Episodic and Chronic Warm Autoimmune hemolytic anemia

Download the report to understand which factors are driving Warm Autoimmune hemolytic anemia epidemiology trends @ Warm Autoimmune hemolytic anemia Epidemiology Forecast [https://www.delveinsight.com/sample-request/warm-autoimmune-hemolytic-anemia-waiha-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Warm Autoimmune hemolytic anemia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Warm Autoimmune hemolytic anemia market or expected to get launched during the study period. The analysis covers Warm Autoimmune hemolytic anemia market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Warm Autoimmune hemolytic anemia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Warm Autoimmune hemolytic anemia Therapies and Key Companies

*
Obexelimab (ZB012): Zenas BioPharma

*
Ianalumab: Novartis/MorphoSys

*
Povetacicept: Alpine Immune Sciences

*
Fostamatinib: Rigel Pharmaceuticals

*
Parsaclisib: Incyte Corporation

*
Rilzabrutinib: Sanofi

*
Nipocalimab: Johnson & Johnson

*
M281: Janssen Research & Development

*
ANX005: Annexon, Inc.

*
APL-2: Apellis Pharmaceuticals, Inc.

*
Fostamatinib disodium: Rigel Pharmaceuticals

*
HMPL-523(300mg PO QD): Hutchison Medipharma Limited

Discover more about therapies set to grab major Warm Autoimmune hemolytic anemia market share @ Warm Autoimmune hemolytic anemia Treatment Market [https://www.delveinsight.com/sample-request/warm-autoimmune-hemolytic-anemia-waiha-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Warm Autoimmune hemolytic anemia Market Drivers

*
Increasing patient population

*
Advancement in research and development

*
Improved clinical trials

*
Patient assistance programs

*
New therapeutic agents

Warm Autoimmune hemolytic anemia Market Barriers

*
Increasing refractory cases

*
Associated co-morbidities

*
Unavailability of better treatment options

*
Therapy failure

*
Lack of disease understanding

*
Unavailability of curative treatment

Scope of the Warm Autoimmune hemolytic anemia Market Report

*
Study Period: 2020-2034

*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

*
Key Warm Autoimmune hemolytic anemia Companies: Zenas BioPharma, Novartis, MorphoSys, Alpine Immune Sciences, Rigel Pharma, Incyte Corp, Sanofi, Johnson & Johnson, Janssen Research & Development, Annexon, Inc., Apellis Pharma, Rigel Pharmaceuticals, Hutchison Medipharma Limited, and others

*
Key Warm Autoimmune hemolytic anemia Therapies: Obexelimab (ZB012), Ianalumab, Povetacicept, Fostamatinib, Parsaclisib, Rilzabrutinib, Nipocalimab, M281, ANX005, APL-2, Fostamatinib disodium, HMPL-523(300mg PO QD), and others

*
Warm Autoimmune hemolytic anemia Therapeutic Assessment: Warm Autoimmune hemolytic anemia current marketed and Warm Autoimmune hemolytic anemia emerging therapies

*
Warm Autoimmune hemolytic anemia Market Dynamics: Warm Autoimmune hemolytic anemia market drivers and Warm Autoimmune hemolytic anemia market barriers

*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies

*
Warm Autoimmune hemolytic anemia Unmet Needs, KOL's views, Analyst's views, Warm Autoimmune hemolytic anemia Market Access and Reimbursement

To know more about Warm Autoimmune hemolytic anemia companies working in the treatment market, visit @ Warm Autoimmune hemolytic anemia Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/warm-autoimmune-hemolytic-anemia-waiha-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Table of Contents

1. Warm Autoimmune hemolytic anemia Market Report Introduction

2. Executive Summary for Warm Autoimmune hemolytic anemia

3. SWOT analysis of Warm Autoimmune hemolytic anemia

4. Warm Autoimmune hemolytic anemia Patient Share (%) Overview at a Glance

5. Warm Autoimmune hemolytic anemia Market Overview at a Glance

6. Warm Autoimmune hemolytic anemia Disease Background and Overview

7. Warm Autoimmune hemolytic anemia Epidemiology and Patient Population

8. Country-Specific Patient Population of Warm Autoimmune hemolytic anemia

9. Warm Autoimmune hemolytic anemia Current Treatment and Medical Practices

10. Warm Autoimmune hemolytic anemia Unmet Needs

11. Warm Autoimmune hemolytic anemia Emerging Therapies

12. Warm Autoimmune hemolytic anemia Market Outlook

13. Country-Wise Warm Autoimmune hemolytic anemia Market Analysis (2020-2034)

14. Warm Autoimmune hemolytic anemia Market Access and Reimbursement of Therapies

15. Warm Autoimmune hemolytic anemia Market Drivers

16. Warm Autoimmune hemolytic anemia Market Barriers

17. Warm Autoimmune hemolytic anemia Appendix

18. Warm Autoimmune hemolytic anemia Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=warm-autoimmune-hemolytic-anemia-waiha-market-poised-for-significant-growth-from-2024-to-2034-reports-delveinsight-rigel-pharma-incyte-crp-sanofi-johnson-johnson-janssen-rd]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Warm Autoimmune hemolytic anemia (WAIHA) Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | Rigel Pharma, Incyte Crp., Sanofi, Johnson & Johnson, Janssen R&D here

News-ID: 3814585 • Views:

More Releases from ABNewswire

BullionBox Reports Growing Investor Partnerships With Gold Firms in 2025
BullionBox Reports Growing Investor Partnerships With Gold Firms in 2025
Investors have watched gold break records in 2025 as economic uncertainty, inflation, and global tensions push more people toward safe assets. Many investors are partnering with gold firms because they see gold as a stable place for their money during unpredictable times. Increasing interest from central banks and growing demand in countries like China have created new opportunities and brought fresh attention to these partnerships. Recent trends show that gold now
Beach Electrical Explains the Benefits of Hiring an Electrician in Felton CA for Home EV Charger Installation
Beach Electrical Explains the Benefits of Hiring an Electrician in Felton CA for …
The electric vehicle revolution is fully underway, and as more residents of Felton, CA make the switch to clean, efficient transportation, the question of home charging becomes paramount. While every electric vehicle comes with a basic cord that can plug into a standard wall outlet, this method is often surprisingly slow and impractical for daily use. To unlock the true convenience and performance of your new EV, a professionally installed
A1 Zuzu HVAC Highlights the Importance of Annual HVAC Maintenance for Modesto CA Homes
A1 Zuzu HVAC Highlights the Importance of Annual HVAC Maintenance for Modesto CA …
In Modesto, CA, where scorching summer temperatures are a way of life, your home's air conditioning system is more than a luxury; it is an essential component of your family's comfort and safety. This critical and complex HVAC system works tirelessly for months on end to provide a cool refuge from the Central Valley heat. However, it is easy to take this system for granted until a problem arises, but
"The Magic of Setting Goals: How Your Dream Can Come True" by Lynn Rossi
Do your dreams feel as if they will remain dreams, not a part of your reality? The Magic of Setting Goals: How Your Dream Can Come True by Lynn Rossi is the guidebook you need. It is filled with practical strategies to overcome obstacles that could be limiting your success. Lynn explores what determines your success, and how to find support during challenges, as well as how you will change

All 5 Releases


More Releases for Warm

Chinese cinnamon: A fragrant and warm guardian
Cinnamon, a spice and medicinal herb originating from ancient China, has earned the reputation of "King of Fragrances" for its unique aroma and rich medicinal value since ancient times. In traditional Chinese culture, cinnamon [https://www.ruiqiaofoods.com/dried-cinnamon-100-natural-healthy-spice-product/] not only symbolizes auspiciousness, happiness, and warmth, but also has become an indispensable part of people's lives with its profound cultural heritage and practical value. Cinnamon, also known as cinnamon or official cinnamon, is the dried
How Big is Warm Water Aquaculture Feed Market?
In 2022, the Global Warm Water Aquaculture Feed Market achieved a value of US$ 4.41 billion. It is projected to escalate to US$ 5.96 billion by 2030, exhibiting a Compound Annual Growth Rate (CAGR) of 3.85% during the forecast period from 2023 to 2030. This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Warm Water Aquaculture Feed market has been growing significantly
Warm Autoimmune Hemolytic Anemia (WAIHA) Market
The Global Warm Autoimmune Hemolytic Anemia (WAIHA) Market is projected to exhibit a high CAGR during the forecast period of 2023-2030. WAIHA, which accounts for 60-70% of autoimmune hemolytic anemia (AIHA) cases, is primarily caused by autoantibodies targeting immunoglobulin G (IgG), leading to red blood cell destruction. Market Dynamics: Diagnostic Advancements: Enhanced Laboratory Techniques: Developments in diagnostic laboratory methods, such as flow cytometry and serologic assays, have improved the accuracy and timeliness of
Warm Slippers Market | Bearpaw, Dearfoams, Hender Scheme, HomeIdeas
Introduction: The introduction to the report serves as a gateway into the comprehensive world of the warm slippers market. As industries continue to evolve and adapt to changing consumer demands and technological advancements, understanding the market dynamics becomes paramount for industry stakeholders. The report takes on the responsibility of offering a profound and all-encompassing analysis of the warm slippers market, catering to the needs of a diverse audience that includes manufacturers,
Spring Into Warm Weather With Olive Juice
Children’s Clothing Company Carries Message Of Fun-In-The-Sun Philadelphia, PA (May 3, 2011) – With spring officially here, the only thing heating up more than the temperature is the fun and fresh looks from children’s apparel line, Olive Juice. From Easter to Memorial Day Weekend, and even Fourth of July, these coming months are all about capturing the fleeting moments of childhood and making lasting memories. Olive Juice has created adorable,
Kerala Beaches are Warm, Inviting and Sensuous
Kerala the land where nature utters its glory through pristine backwaters, palm fringed beaches, tranquil villages and greenery in profusion. The National Geographic Traveler Magazine named Kerala as one of the ‘Ten Paradises of the World’ and ‘Fifty Places of a Lifetime’. This categorization heightens the glory of Kerala across the globe and make it a hotspot for spending a memorable holidays. Several mesmerizing destinations of Kerala promise the best